Scienture Holdings, Inc. balance sheet
At the end of fiscal 2025, Scienture Holdings, Inc. had total assets of $84.2m, total liabilities of $14.1m and shareholders' equity of $70.1m. It held $6.7m in cash against $2.0m of debt: net cash of $4.7m.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0 | 1 | 0 | 0 | 0 | 1 | 3 | 6 | 3 | 1 | 0 | 0 | 7 | 8 |
| Receivables | 0 | 0 | — | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Inventory | 0 | 0 | 0 | — | — | 0 | 0 | 1 | 0 | 0 | 0 | — | 0 | 0 |
| Total current assets | 0 | 1 | 1 | 0 | 1 | 1 | 4 | 9 | 4 | 2 | 3 | 6 | 8 | 9 |
| Goodwill | — | — | — | — | — | 1 | 1 | — | 0 | 0 | — | 21 | — | — |
| Total assets | 0 | 1 | 2 | 0 | 1 | 2 | 6 | 10 | 6 | 4 | 13 | 105 | 84 | 88 |
| Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 1 | 1 |
| Deferred revenue (current) | — | — | — | — | — | — | — | 0 | — | — | — | — | — | — |
| Total current liabilities | 0 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 12 | 8 | 3 | 3 |
| Short-term debt | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | 0 | 0 | 1 | 1 | 0 | — | — | 0 | 0 | 3 | — | — |
| Total debt | 0 | 0 | 0 | 1 | 1 | 1 | 0 | — | 0 | 1 | 7 | 6 | 2 | — |
| Total liabilities | — | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 12 | 26 | 14 | 24 |
| Shareholders' equity | 0 | 1 | 0 | −1 | −0 | 1 | 4 | 9 | 4 | 1 | 1 | 79 | 70 | 64 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | — | — | — | — | — | — | — | −0 | — | — | — | — |
| Net debt (negative = net cash) | −0 | −1 | 0 | 1 | 0 | −0 | −3 | −6 | −3 | −1 | 7 | 5 | −5 | −8 |
| Shares outstanding | — | — | — | — | — | — | 13m | 16m | 16m | 19m | 18m | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 0 | 0 | 0 | — | 1 | 1 | 1 | 0 |
| Inventory | 0 | — | — | — | 0 | 0 | 0 | 0 |
| Total current assets | 7 | 6 | 8 | 1 | 1 | 8 | 5 | 9 |
| Goodwill | 8 | 21 | 21 | 21 | 21 | — | — | — |
| Total assets | 94 | 105 | 84 | 84 | 105 | 84 | 81 | 88 |
| Accounts payable | 3 | 3 | 3 | 3 | 4 | 1 | 1 | 1 |
| Total current liabilities | 5 | 8 | 7 | 8 | 7 | 3 | 3 | 3 |
| Long-term debt | 2 | 3 | 3 | 4 | 2 | — | — | — |
| Total debt | 2 | 3 | 3 | 4 | 2 | — | — | — |
| Total liabilities | 9 | 26 | 25 | 26 | 22 | 14 | 14 | 24 |
| Shareholders' equity | 85 | 79 | 81 | 78 | 83 | 70 | 67 | 64 |
| Non-controlling interests and other (assets − liabilities − equity) | — | — | −22 | −20 | — | — | — | — |
| Shares outstanding | 9m | 9m | 13m | 16m | 23m | 41m | 41m | 41m |
Compare with peers
- 60 Degrees Pharmaceuticals, Inc. balance sheet
- China SXT Pharmaceuticals, Inc. balance sheet
- Lipocine Inc. balance sheet
- Nutriband Inc. balance sheet
- Akanda Corp. balance sheet
Head to head: SCNX vs SXTPSCNX vs SXTCLPCN vs SCNXAKAN vs SCNX
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies